$3.11
-0.08[-2.51%]
At close: May 3
$3.11
0[0.00%]
After Hours: 9:18AM EDT
Leap Therapeutics
(NASDAQ:LPTX)Latest News for Leap Therapeutics Stock (NASDAQ:LPTX)
Leap Therapeutics Stock (NASDAQ: LPTX)
Categories: All
Friday, April 19, 2024
Thursday, April 11, 2024
Wednesday, March 20, 2024
Tuesday, March 19, 2024
Monday, March 18, 2024
Tuesday, January 02, 2024
- Leap Therapeutics shares are trading higher after the company announced it completed enrollment in its randomized controlled Part C of the DisTingGuish study of DKN-01 for the treatment of Gastric Cancer Patients.Benzinga Newsdesk - Jan 2, 2024, 11:32AM
- Leap Therapeutics Concludes Enrollment In The Randomized Controlled Part C Of Distinguish Study Of DKN-01 In Combination With BeiGene's Tislelizumab And Chemotherapy In Patients With Advanced Gastroesophageal Junction And Gastric CancerBenzinga Newsdesk - Jan 2, 2024, 7:03AM
Monday, November 27, 2023
Friday, November 24, 2023
Tuesday, November 21, 2023
Monday, November 20, 2023
Tuesday, November 14, 2023
Monday, November 13, 2023
Monday, October 16, 2023
Monday, October 09, 2023
Tuesday, October 03, 2023
Thursday, September 21, 2023
Friday, September 15, 2023
Friday, September 08, 2023
Tuesday, August 15, 2023
Tuesday, August 08, 2023
Friday, July 28, 2023
Thursday, July 27, 2023
Wednesday, July 26, 2023
Thursday, July 13, 2023
Wednesday, July 12, 2023
Friday, June 23, 2023
Tuesday, June 20, 2023
Friday, June 09, 2023
Tuesday, June 06, 2023
Tuesday, May 23, 2023
Thursday, May 18, 2023
Wednesday, May 17, 2023
Tuesday, May 16, 2023
Monday, May 15, 2023
Monday, April 24, 2023
Thursday, April 13, 2023
Wednesday, April 12, 2023
Monday, March 27, 2023
- Stocks That Hit 52-Week Lows On MondayBenzinga Insights - Mar 27, 2023, 1:22PM
- What 5 Analyst Ratings Have To Say About Leap TherapeuticsBenzinga Insights - Mar 27, 2023, 11:01AM
- HC Wainwright & Co. Reiterates Buy on Leap Therapeutics, Maintains $2.5 Price TargetBenzinga Newsdesk - Mar 27, 2023, 6:11AM